3034 studies found for:    5-HT
Show Display Options
Rank Status Study
1 Recruiting Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors
Condition: Chemotherapy-Induced Nausea and Vomiting
Interventions: Drug: Fosaprepitant;   Drug: Dexamethasone;   Drug: 5HT3
2 Recruiting Evaluation of [11C]Cimbi-36 as an Agonist PET Radioligand for Imaging of 5-HT2A Receptors
Condition: Healthy
Interventions: Drug: Citalopram and Pindolol;   Dietary Supplement: Acute tryptophan depletion
3 Withdrawn Imaging Serotonin 5HT1A Receptors in Patients With Major Depressive Disorder
Conditions: Major Depression;   Unipolar Depression;   Depression;   Anxiety Disorder
Intervention: Other: Antidepressant (SSRI)
4 Recruiting Investigating Serotonin Signalling in IBD Patients
Condition: Inflammatory Bowel Disease
Intervention:
5 Completed Evaluation of [18F]MPPF as a Brain Tracer of Serotonin Receptor 5HT1a
Condition: Parkinson Disease
Intervention: Drug: [18F]MPPF
6 Recruiting Hiperemezis and Serotonin Elevated Serum Serotonin Levels in Hyperemesis
Conditions: Nausea;   Vomiting;   Markedly Reduced Food Intake;   Severe Dehydration
Intervention:
7 Completed Investigation of Serotonin Neurotransmission in MDMA Users Using Combinated Dexfenfluramine Challenge and PET Imaging
Conditions: Amphetamine-Related Disorders;   Amphetamine Abuse
Intervention: Drug: dexfenfluramine
8 Completed Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male Volunteers
Condition: Migraine
Interventions: Drug: Rapimelt;   Drug: [11C]AZ10419369
9 Completed Tryptophan, Serotonin and Kynurenine in Septic Shock
Condition: Shock, Septic
Intervention:
10 Completed Association of 5-HT3 Receptor Gene Polymorphism With the Efficiency of Ondansetron for Postoperative Nausea and Vomiting
Condition: Post Operative Nausea and Vomiting
Intervention: Dietary Supplement: administration of ondanstron and screening of genomic DNA
11 Completed Examination of Brain Serotonin Receptors in Patients With Mood Disorders
Conditions: Mood Disorder;   Bipolar Disorder;   Depression
Intervention:
12 Terminated 12 Week Safety Trial of Flibanserin in Depressed Women Taking a Selective Serotonin Reuptake Inhibitor or Norepinephrine Serotonin Reuptake Inhibitor With Decreased Sexual Desire and Distress
Conditions: Sexual Dysfunctions, Psychological;   Depression
Interventions: Drug: flibanserin 2;   Drug: placebo;   Drug: flibanserin 1
13 Completed Serotonin Transporters in Alcoholism
Condition: Alcoholism
Intervention:
14 Unknown  Effectiveness of the Dual Serotonin Norepinephrine Reuptake Inhibitor Desvenlafaxine Succinate in Healthy Volunteers
Condition: Healthy
Intervention: Drug: Desvenlafaxine succinate
15 Completed Serotonin Transporter Genetic Variation and Amygdala Responses to Antidepressant Medications in Major Depression
Condition: Major Depressive Disorder
Intervention: Drug: Quetiapine XR (extended release)
16 Terminated Study of PET Scans and Serotonin in Hot Flashes Treatment
Condition: Hot Flashes
Interventions: Drug: Paroxetine controlled-release;   Drug: Conjugated equine estrogen
17 Enrolling by invitation Serotonin Transporter Density in Late-life Depression With and Without Dementia
Condition: Melancholia
Intervention: Drug: I-123 ADAM
18 Completed Sex Steroids and the Serotonin Transporter
Condition: Transsexualism
Interventions: Drug: Testolactone undecanoate;   Drug: Lynestrenol;   Drug: Cyproterone Acetate;   Drug: Estradiol;   Drug: 5-alpha reductase inhibitor
19 Completed Brain Imaging of Serotonin Transporters in the Brain
Conditions: Healthy;   Serotonin Transporter
Intervention:
20 Completed Effects of Serotonin Excess on Bone in Carcinoid Syndrome
Condition: Carcinoid Syndrome
Intervention:

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years